| 000 | 01249 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250518080609.0 | ||
| 264 | 0 | _c20210208 | |
| 008 | 202102s 0 0 eng d | ||
| 022 | _a1873-6815 | ||
| 024 | 7 |
_a10.1016/j.exger.2020.110831 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBraidy, Nady | |
| 245 | 0 | 0 |
_aNAD+ therapy in age-related degenerative disorders: A benefit/risk analysis. _h[electronic resource] |
| 260 |
_bExperimental gerontology _c04 2020 |
||
| 300 |
_a110831 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Systematic Review | ||
| 650 | 0 | 4 |
_aAging _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammation _xmetabolism |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNAD _xmetabolism |
| 650 | 0 | 4 |
_aNeurodegenerative Diseases _xmetabolism |
| 650 | 0 | 4 |
_aNiacinamide _xanalogs & derivatives |
| 650 | 0 | 4 |
_aNicotinamide Mononucleotide _xmetabolism |
| 650 | 0 | 4 | _aOxidative Stress |
| 650 | 0 | 4 | _aPyridinium Compounds |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRisk Assessment |
| 700 | 1 | _aLiu, Yue | |
| 773 | 0 |
_tExperimental gerontology _gvol. 132 _gp. 110831 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.exger.2020.110831 _zAvailable from publisher's website |
| 999 |
_c30499655 _d30499655 |
||